Kazunori Noguchi
Omuta, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 12, 2022
First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study.
Journal: Cancer medicine
Published: September 09, 2021
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.
Journal: Cancers
Published: January 17, 2021
Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study.
Journal: Cancers
Published: November 30, 2020
Prevalence and profiles of ramucirumab-associated severe ascites in patients with hepatocellular carcinoma.
Journal: Molecular and clinical oncology
Published: November 16, 2020
Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study.
Journal: Cancers
Published: June 20, 2020
Granulocyte-colony stimulating factor producing mucinous cystic neoplasm with an associated invasive carcinoma of the pancreas.
Journal: Oncology letters
Published: July 01, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026